MRDVX | VIVIX | MRDVX / VIVIX | |
Total Expense Ratio | 1.22 | 0.04 | 3,050% |
Annual Report Gross Expense Ratio | 1.29 | 0.04 | 3,225% |
Fund Existence | 23 years | 27 years | - |
Gain YTD | 12.284 | 9.748 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.7B | 208B | 9% |
Annual Yield % from dividends | 1.22 | 2.09 | 58% |
Returns for 1 year | 2.00 | 4.64 | 43% |
Returns for 3 years | 23.87 | 42.98 | 56% |
Returns for 5 years | 23.04 | 71.78 | 32% |
Returns for 10 years | -1.63 | 129.40 | -1% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MAYT | 36.10 | 0.10 | +0.28% |
AllianzIM U.S. Large Cp Buffer10 May ETF | |||
TOTL | 40.76 | -0.04 | -0.10% |
SPDR® DoubleLine® Total Return Tact ETF | |||
BSMW | 25.17 | -0.05 | -0.18% |
Invesco BulletShares 2032 Muncpl Bd ETF | |||
THNR | 23.36 | -0.37 | -1.56% |
Amplify Weight Loss Drug & Treatment ETF | |||
UVIX | 11.78 | -2.29 | -16.28% |
2x Long VIX Futures ETF |